Leruze

Lisinopril, the active ingredient in Leruze, is an ACE inhibitor presented as an oral tablet for oral use. It is employed to lower high blood pressure and to improve outcomes in patients with heart failure or post‑myocardial infarction.

GNH USA supplies Leruze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from comprehensive technical support, regulatory documentation, and timely delivery across multiple continents.

Lisinopril is used to manage conditions within the cardiovascular disease pathway, primarily by controlling blood pressure and reducing cardiac workload. - Hypertension: lowers systemic blood pressure, decreasing risk of stroke and kidney damage. - Heart failure: improves symptoms and reduces hospitalization by decreasing afterload. - Post‑myocardial infarction: lowers mortality and prevents remodeling of the heart muscle.

Lisinopril may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Cough: dry, persistent cough. - Dizziness: especially upon standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness. - Hyperkalemia: elevated blood potassium levels. - Hypotension: low blood pressure, particularly after first dose.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Renal impairment: worsening kidney function. - Hepatitis: signs of liver injury. - Neutropenia: reduced white blood cell count. - Severe hypotension: marked drop in blood pressure causing fainting.

When prescribing Lisinopril, clinicians should observe several safety considerations to minimize risk. - Pregnancy: contraindicated in second and third trimesters due to fetal toxicity (Category D). - Renal function: assess baseline creatinine and monitor regularly. - Hyperkalemia risk: avoid concurrent potassium‑sparing diuretics or supplements. - Hypotension: start at low dose in patients prone to low blood pressure. - Drug interactions: review concomitant medications for ACE inhibitor interactions. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Lisinopril can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Aliskiren: combined use in diabetes or renal impairment may increase risk of renal dysfunction. - Lithium: may increase lithium levels, risking toxicity. - NSAIDs: can reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Potassium‑sparing diuretics (e.g., spironolactone): may cause hyperkalemia. - Angiotensin II receptor blockers: additive blood pressure lowering, monitor for hypotension. - Diuretics (thiazides): may enhance hypotensive effect, adjust dose as needed.